1
|
Zhang Y, Liu J, Yang G, Zou J, Tan Y, Xi E, Geng Q, Wang Z. Asiaticoside Inhibits Growth and Metastasis in Non-Small Cell Lung Cancer by Disrupting EMT via Wnt/β-Catenin Pathway. ENVIRONMENTAL TOXICOLOGY 2024. [PMID: 38888371 DOI: 10.1002/tox.24359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Revised: 04/07/2024] [Accepted: 05/11/2024] [Indexed: 06/20/2024]
Abstract
Non-small cell lung cancer (NSCLC) is the primary inducer of cancer-related death worldwide. Asiaticoside (ATS) is a triterpenoid saponin that has been indicated to possess an antitumor activity in several malignancies. Nonetheless, its detailed functions in NSCLC remain unclarified. In this study, NSCLC cells were exposed to various doses of ATS. Functional experiments were employed to estimate the ATS effect on NSCLC cell behaviors. Western blotting was implemented for protein expression evaluation. A xenograft mouse model was established to assess the ATS effect on NSCLC in vivo. The results showed that ATS restrained NSCLC cell proliferation, cell cycle progression, migration, and invasiveness. ATS reversed TGF-β-induced promotion in epithelial-mesenchymal transition (EMT). Mechanistically, ATS inhibited Wnt/β-catenin signaling in NSCLC. Upregulating β-catenin restored ATS-mediated suppression of NSCLC cell aggressiveness. Moreover, ATS administration repressed tumorigenesis in tumor-bearing mice. In conclusion, ATS represses growth and metastasis in NSCLC by blocking EMT via the inhibition of Wnt/β-catenin signaling.
Collapse
Affiliation(s)
- Yanan Zhang
- Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China
| | - Jiangyong Liu
- Department of Radiography, Central Theater Command General Hospital of Chinese People's Liberation Army, Wuhan, China
| | - Gang Yang
- Department of Cardiothoracic Surgery, Central Theater Command General Hospital of Chinese People's Liberation Army, Wuhan, China
| | - Jiani Zou
- Department of Radiography, Central Theater Command General Hospital of Chinese People's Liberation Army, Wuhan, China
| | - Yan Tan
- Department of Cardiothoracic Surgery, Central Theater Command General Hospital of Chinese People's Liberation Army, Wuhan, China
| | - Erping Xi
- Department of Cardiothoracic Surgery, Central Theater Command General Hospital of Chinese People's Liberation Army, Wuhan, China
| | - Qing Geng
- Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China
| | - Zheng Wang
- Department of Cardiothoracic Surgery, Central Theater Command General Hospital of Chinese People's Liberation Army, Wuhan, China
| |
Collapse
|
2
|
Jawad MU, Pollock BH, Wise BL, Zeitlinger LN, O' Donnell EF, Carr-Ascher JR, Cizik A, Ferrell B, Thorpe SW, Randall RL. Socioeconomic and insurance-related disparities in disease-specific survival among patients with metastatic bone disease. J Surg Oncol 2022; 127:159-173. [PMID: 36121418 DOI: 10.1002/jso.27097] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Revised: 08/22/2022] [Accepted: 09/05/2022] [Indexed: 11/07/2022]
Abstract
BACKGROUND Approximately 5% of cancer patients in the United States presented with metastatic bone disease (MBD) at diagnosis. Current study explores the disparities in survival for patients with MBD. METHODS Patients with the diagnosis of MBD at presentation for the five most common primary anatomical sites were extracted from Surveillance, Epidemiology, and End Results Census tract-level dataset (2010-2016). Kaplan-Meier and Cox Proportional Hazard models were used to evaluate survival, and prognostic factors for each cohort. Prognostic significance of socioeconomic status (SES) and insurance status were ascertained. RESULTS The five most common anatomical-sites with MBD at presentation included "lung" (n = 59 739), "prostate" (n = 19 732), "breast" (n = 16 244), "renal and urothelium" (n = 7718) and "colon" (n= 3068). Lower SES was an independent risk factor for worse disease-specific survival (DSS) for patients with MBD originating from lung, prostate, breast and colon. Lack of insurance was an independent risk factor for worse DSS for MBD patients with primary tumors in lung and breast. CONCLUSIONS MBD patients from the five most common primary sites demonstrated SES and insurance-related disparities in disease-specific survival. This is the first and largest study to explore SES and insurance-related disparities among patients specifically afflicted with MBD. Our findings highlight vulnerability of patients with MBD across multiple primary sites to financial toxicity.
Collapse
Affiliation(s)
- Muhammad Umar Jawad
- Department of Orthopedic Surgery, Samaritan Health System, Corvallis, Oregon, USA
| | - Brad H Pollock
- Department of Public Health Sciences, UC Davis School of Medicine, Sacramento, California, USA
| | - Barton L Wise
- Department of Internal Medicine, UC Davis School of Medicine, Sacramento, California, USA.,Department of Orthopaedic Surgery, UC Davis School of Medicine, Sacramento, California, USA
| | - Lauren N Zeitlinger
- Department of Orthopaedic Surgery, UC Davis School of Medicine, Sacramento, California, USA
| | - Edmond F O' Donnell
- Department of Orthopaedic Surgery, UC Davis School of Medicine, Sacramento, California, USA
| | - Janai R Carr-Ascher
- Department of Internal Medicine, UC Davis School of Medicine, Sacramento, California, USA.,Department of Orthopaedic Surgery, UC Davis School of Medicine, Sacramento, California, USA
| | - Amy Cizik
- Department of Orthopaedic Surgery, University of Utah, Salt Lake City, Utah, USA
| | - Betty Ferrell
- Department of Nursing and Palliative Care, City of Hope, Duarte, California, USA
| | - Steven W Thorpe
- Department of Orthopaedic Surgery, UC Davis School of Medicine, Sacramento, California, USA
| | - R Lor Randall
- Department of Orthopaedic Surgery, UC Davis School of Medicine, Sacramento, California, USA
| |
Collapse
|